Polar Asset Management Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,000
| Closed | -$576K | – | 1049 |
|
|
2023
Q2 | $576K | Sell |
15,000
-134,600
| -90% | -$5.17M | 0.01% | 530 |
|
|
2023
Q1 | $3.46M | Hold |
149,600
| – | – | 0.05% | 378 |
|
|
2022
Q4 | $3.92M | Hold |
149,600
| – | – | 0.05% | 450 |
|
|
2022
Q3 | $2.94M | Sell |
149,600
-167,011
| -53% | -$3.28M | 0.04% | 592 |
|
|
2022
Q2 | $5.54M | Buy |
316,611
+134,311
| +74% | +$2.35M | 0.06% | 403 |
|
|
2022
Q1 | $2.98M | Hold |
182,300
| – | – | 0.03% | 524 |
|
|
2021
Q4 | $2.97M | Buy |
+182,300
| New | +$2.97M | 0.03% | 491 |
|